These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37822449)

  • 1. Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes.
    Klein A; Loupy A; Stegall M; Helanterä I; Kosinski L; Frey E; Aubert O; Divard G; Newell K; Meier-Kriesche HU; Mannon R; Dumortier T; Aggarwal V; Podichetty JT; O'Doherty I; Gaber AO; Fitzsimmons WE
    Transpl Int; 2023; 36():11951. PubMed ID: 37822449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes.
    Klein A; Loupy A; Stegall M; Helanterä I; Kosinski L; Frey E; Aubert O; Divard G; Newell K; Meier-Kriesche HU; Mannon RB; Dumortier T; Aggarwal V; Podichetty JT; O'Doherty I; Gaber AO; Fitzsimmons WE;
    Am J Transplant; 2023 Oct; 23(10):1496-1506. PubMed ID: 37735044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival.
    Klein A; Kosinski L; Loupy A; Frey E; Stegall M; Helanterä I; Newell K; Meier-Kriesche HU; Mannon RB; Fitzsimmons WE;
    Am J Transplant; 2024 Oct; 24(10):1784-1793. PubMed ID: 38642711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation.
    Nickerson PW; Balshaw R; Wiebe C; Ho J; Gibson IW; Bridges ND; Rush DN; Heeger PS
    Am J Transplant; 2021 Apr; 21(4):1503-1512. PubMed ID: 32956576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for optimized immunosuppression in elderly kidney transplant recipients.
    Lehner LJ; Staeck O; Halleck F; Liefeldt L; Bamoulid J; Budde K
    Transplant Rev (Orlando); 2015 Oct; 29(4):237-9. PubMed ID: 26411381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.
    OʼConnell PJ; Kuypers DR; Mannon RB; Abecassis M; Chadban SJ; Gill JS; Murphy B; Nickerson PW; Schold JD; Stock PG; Seron D; Alloway RR; Bromberg JS; Budde K; Jordan SC; Legendre C; Lefaucheur C; Sarwall M; Segev DL; Stegall MD; Tullius SG; Wong G; Woodle ES; Ascher N; Morris RE
    Transplantation; 2017 Jul; 101(7):1527-1534. PubMed ID: 28207630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.
    Brook MO; Hester J; Petchey W; Rombach I; Dutton S; Bottomley MJ; Black J; Abdul-Wahab S; Bushell A; Lombardi G; Wood K; Friend P; Harden P; Issa F
    BMJ Open; 2022 Apr; 12(4):e061864. PubMed ID: 35428650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression in uterus transplantation: from transplant to delivery.
    D'Amico G; Del Prete L; Eghtesad B; Hashimoto K; Miller C; Tzakis A; Quintini C; Falcone T
    Expert Opin Pharmacother; 2023 Jan; 24(1):29-35. PubMed ID: 35723045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study.
    Aubert O; Divard G; Pascual J; Oppenheimer F; Sommerer C; Citterio F; Tedesco H; Chadban S; Henry M; Vincenti F; Srinivas T; Watarai Y; Legendre C; Bernhardt P; Loupy A
    BMJ Open; 2021 Oct; 11(10):e052138. PubMed ID: 34620664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current pharmacotherapeutical options for the prevention of kidney transplant rejection.
    Schaefer SM; Süsal C; Sommerer C; Zeier M; Morath C
    Expert Opin Pharmacother; 2013 Jun; 14(8):1029-41. PubMed ID: 23560807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation.
    Alloway RR; Woodle ES; Abramowicz D; Segev DL; Castan R; Ilsley JN; Jeschke K; Somerville KT; Brennan DC
    Am J Transplant; 2019 Aug; 19(8):2252-2261. PubMed ID: 30838775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate Endpoints for Late Kidney Transplantation Failure.
    Naesens M; Budde K; Hilbrands L; Oberbauer R; Bellini MI; Glotz D; Grinyó J; Heemann U; Jochmans I; Pengel L; Reinders M; Schneeberger S; Loupy A
    Transpl Int; 2022; 35():10136. PubMed ID: 35669974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients.
    Harden PN; Game DS; Sawitzki B; Van der Net JB; Hester J; Bushell A; Issa F; Brook MO; Alzhrani A; Schlickeiser S; Scotta C; Petchey W; Streitz M; Blancho G; Tang Q; Markmann J; Lechler RI; Roberts ISD; Friend PJ; Hilton R; Geissler EK; Wood KJ; Lombardi G
    Am J Transplant; 2021 Apr; 21(4):1603-1611. PubMed ID: 33171020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in kidney transplantation.
    Djamali A; Premasathian N; Pirsch JD
    Semin Nephrol; 2003 May; 23(3):306-16. PubMed ID: 12838499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report.
    Mannon RB; Morris RE; Abecassis M; Axelrod D; Bala S; Friedman GS; Heeger PS; Lentine KL; Loupy A; Murphy B; Nickerson P; Sarwal M; O'Doherty I; Spear N; Karpen SR
    Am J Transplant; 2020 Jun; 20(6):1495-1502. PubMed ID: 32090461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.
    Hong T; Zhang M; Fan J
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009698. PubMed ID: 26457607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
    Sawitzki B; Harden PN; Reinke P; Moreau A; Hutchinson JA; Game DS; Tang Q; Guinan EC; Battaglia M; Burlingham WJ; Roberts ISD; Streitz M; Josien R; Böger CA; Scottà C; Markmann JF; Hester JL; Juerchott K; Braudeau C; James B; Contreras-Ruiz L; van der Net JB; Bergler T; Caldara R; Petchey W; Edinger M; Dupas N; Kapinsky M; Mutzbauer I; Otto NM; Öllinger R; Hernandez-Fuentes MP; Issa F; Ahrens N; Meyenberg C; Karitzky S; Kunzendorf U; Knechtle SJ; Grinyó J; Morris PJ; Brent L; Bushell A; Turka LA; Bluestone JA; Lechler RI; Schlitt HJ; Cuturi MC; Schlickeiser S; Friend PJ; Miloud T; Scheffold A; Secchi A; Crisalli K; Kang SM; Hilton R; Banas B; Blancho G; Volk HD; Lombardi G; Wood KJ; Geissler EK
    Lancet; 2020 May; 395(10237):1627-1639. PubMed ID: 32446407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
    Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G;
    Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.